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ABSTRACT 
Objective: Colorectal cancer (CRC) contributes to 9.7% of all cancer, and its pathogenesis is related to chronic inflammation. However, current 
cancer therapy options are lacking, and peptide in food has become popular among researchers because it is cheap, easy to get, has a low toxicity, 
and is a promising cancer-preventing agent. This research aimed to investigate whether lunasin from soybeans can reduce the expression of pro-
inflammatory cytokine TNF-α in colonic epithelial cells. 
Methods: Thirty Swiss Webster mice were randomly allocated to six groups. One group was normal, and in five groups, carcinogenesis was induced 
using azoxymethane (AOM) and dextran sodium sulfate (DSS). The mice were then given nothing (negative control), aspirin (positive control), and 
lunasin-rich soybean extract (LSE) in three different doses (250, 300, and 350 mg/kgBW) for four weeks. Distal colon tissue was 
immunohistochemically stained and then observed under a light microscope with 400X magnification to count epithelial cells, based on their color. 
The index was calculated using optical density scores. 
Results: LSE was shown to decrease the expression of tumor necrosis factor (TNF)-α. This decrease was statistically significant between the 
negative control and a dose of 300 mg/kgBW (p=0.016) and 350 mg/kgBW (p=0.009), yet it was not significant with a dose of 250 mg/kgBW 
(p=0.754).  
Conclusion: a dose of 300 mg/kgBW or higher of LSE can reduce the expression of TNF-α. 
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INTRODUCTION 
Colorectal cancer (CRC) is the third most common type of cancer in 
men and the second most common type of cancer in women, 
contributing to 9.7% of all cancer worldwide [1, 2] In 2012, 746,000 
men and 614,000 women were diagnosed CRC, and 694.000 people 
died from CRC [2]. Its incidence is correlated with genetic factors and 
lifestyle, such as an increased intake of red and processed meat, a high-
fat diet, a decreased intake of high-fiber food (e. g., vegetables and 
fruits), high alcohol intake, and smoking. This can lead to chronic 
inflammation, which plays major role in CRC pathogenesis [3, 4]. 
The high prevalence of cancer and cost of its treatment have 
amplified the importance of CRC screening and the promotion of a 
healthy lifestyle. Although the incidence of CRC decreased by 34% 
from 2000 to 2014 in the>50 age group, there was an increase of 13% 
in the<50 age group during the same period [5]. In addition, current 
cancer therapies, such as surgery, radiation, chemotherapy, and 
immunotherapy are far from flawless; radiation and chemotherapy 
have a low therapeutic index and high toxicity, and sometimes, 
tumor cells can grow back. Meanwhile, immunotherapy shows 
toxicity and autoimmunity, and its effects quickly disappear. 
Therefore, innovative therapeutic strategies are needed to reduce 
the risk of cancer and modify tumors by utilizing knowledge in 
tumor biology and tumor-host interactions [6]. 
In recent years, peptides and proteins in foods are gaining attention 
as a cancer adjuvant therapy. Unlike drug molecules, peptides have a 
higher affinity and specificity to a target organ, a lower toxicity, and 
better penetration in tissue [7]. Therefore, there is a possibility of 
using proteins and peptides as cancer prevention methods in the 
phases of initiation, promotion, and progression [8]. One interesting 
peptides for this purpose is lunasin, a peptide consisting of 43 amino 
acids isolated from soybeans. One of its anticancer mechanisms is its 
anti-inflammatory activity, which it does by suppressing nuclear 
factor-kappa beta (NF-κB) [9] NF-κB activation increases 
inflammatory cytokines, such as interleukin (IL)-6 and tumor 
necrosis factor (TNF)-α, which are proven in cancer pathogenesis. In 
an in vitro study, the administration of lunasin for 24 h on 
inflammatory-induced macrophage using lipopolysaccharide (LPS) 
showed that lunasin significantly reduced IL-6 and TNF-α, as well as 
reactive oxygen species (ROS) [10]. 
Until now, there has been no in vivo research focused on the immune 
system in cancer carcinogenesis that observes TNF-α expression 
after the administration of lunasin from soybean extract. Therefore, 
in this paper, we use animal models that were induced with 
colorectal carcinogenesis using dextran sodium sulfate (DSS) and 
azoxymethane (AOM). Lunasin was administered orally to measure 
the expression of TNF-α on colonic epithelial cells. 
MATERIALS DAN METHODS 
Lunasin extraction 
Grobogan soybean variety, obtained from Indonesia Legumes and 
Tuber Crops Research Institute in Malang, East Java, Indonesia, was 
used in this study because it is one of the superior varieties and has 
the highest protein content. The soybean was pressed to separate its 
oil and obtain the residue, which is in the form of a powder. The 
residue was macerated with phosphate buffer saline (1:5) for 60 min, 
then filtrated thrice. The procedure of maceration was based on that 
of previous studies [11, 12]. The filtrate was dried in an evaporator 
at 50 °C. The concentration of lunasin in soybean extract was 
determined using high-performance liquid chromatography (HPLC). 
Animals 
Thirty male Swiss Webster mice (12 w old and±25 g body weight) 
were supplied by the Agency for Health Research and Development, 
Ministry of Health, of the Republic of Indonesia. The mice were 
acclimatized for one week in the Pathological Anatomy 
Laboratorium of the Faculty of Medicine, University of Indonesia, 
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under controlled temperature (25 °C), humidity (55%), and light (12 
h/12 h light/dark cycle), and with free access to food and drink. 
Their physical condition was examined, and only the healthy ones 
were chosen for use in the experiment. 
Colorectal carcinogenesis induction 
The method for the induction of colorectal carcinogenesis was 
adopted from Kusmardi et al. [13]. Mice were given a single 
intraperitoneal (i. p.) injection of 10 mg/kgBW azoxymethane (AOM), 
diluted in 0.9% NaCl, early in week one. Throughout the second 
week, the mice were given food and drink containing dextran 
sodium sulfate (DSS) at 2%, daily. 
Experimental group 
Mice were randomly allocated to six experimental groups, as follows: 
the normal group, in which mice did not receive AOM/DSS but only 
received oral administration of physiological saline for 4 w; the 
negative control group, in which mice were given AOM/DSS followed 
by oral administration of physiological saline for 4 w; the positive 
control group, in which mice were given AOM/DSS, followed by oral 
administration of 150 mg/kgBW aspirin for 4 w; and the lunasin-
rich soybean extract (LSE) treatment group, in which mice received 
AOM/DSS, followed by the oral administration of LSE (250, 300, or 




Fig. 1: Experimental groups for the colorectal carcinogenesis model 
 
Immunohistochemistry 
Distal colorectal tissue obtained from the mice was washed with water 
and fixed in buffered formalin 10%. The tissue was embedded in paraffin 
block, then cut into 4 µm-thick sections. Sections were incubated with 
primary (anti-TNF-α) antibodies (1:100 v/v) at room temperature for 
one hour. After a 10-minute wash, the samples were incubated with 
secondary antibodies at room temperature for 15 min. TrekAvidin-HRP 
was added to the samples and incubated at room temperature. After two 
15-minute washes, chromogen (diamino benzidine) was added to the 
samples, and the reaction took 30 seconds. The samples were washed 
with water, soaked in lithium carbonate solutions for one minute, and 
washed with water again. They were then dehydrated with ethanol. 
Quantification of TNF-α expression 
The samples were observed under light microscope (400X 
magnification), and five fields of view were randomly taken of each 
of the samples. Epithelial cells that did not express TNF-α in their 
cytoplasm appeared blue (negative), while cells that expressed TNF-
α appeared brown (positive). The intensity of this brown color was 
differentiated into three classes: high, moderate, and low positive 
(fig. 2). The number of cells in each group was transformed into a 
percentage (%). The index of TNF-α expression was calculated using 




Fig. 2: Intensity difference of cells that expressed TNF-α under light microscope (400X magnification) 
 
Statistical analysis 
Data were analyzed using SPSS version 23.0 for Mac. Data is 
presented as mean±standard deviation. Because the distribution of 
data was normal, yet the variance was not homogenous, differences 
in the index expression of TNF-α among the groups were assessed 
using Kruskal–Wallis and Mann–Whitney U tests. A p value of<0.05 
was considered statistically significant. 
RESULTS 
The more TNF-α was expressed in the cytoplasm of colonic epithelial 
cells, the greater intensity of the brown color that appeared after 
immunohistochemical staining was. It was seen that the greatest 
intensity of brown color occurred in the negative control group, 
while the lowest intensity was found in the normal and LSE 350 
mg/kg BW groups. In the LSE group, TNF-α expression was 
decreased progressively, as shown in D, E, and F of fig. 3. 
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Fig. 3: Expression of TNF-α in colonic epithelial cells after immunohistochemical staining (400X magnification). Normal (A); negative 
control (B); positive control (C); LSE-250 (D); LSE-300 (E); LSE-350 (F) 
 
A statistically significant difference was seen in the index 
expression of TNF-α between the normal and negative control 
(p=0.009), LSE-250 (p=0.028), and LSE-300 (p=0.009) groups; 
between the negative control and positive control (p=0.009), 
LSE-300 (p=0.016), and LSE-350 (p=0.009) groups; between the 
positive control and LSE-300 (p=0.028) group; between the LSE-
250 and LSE-350 (p=0.047) groups; and between the LSE-300 
and LSE-350 (p=0.009) groups. 
 
 
Fig. 4: Mean index expression of TNF-α (p=0.001); *p<0.05 is statistically significant 
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DISCUSSION 
Colorectal carcinogenesis with AOM/DSS 
Chronic inflammation, as occurs in inflammatory bowel disease (IBD), 
has a role in carcinogenesis [14, 15]. Okayasu et al.15 simulated 
colorectal carcinogenesis as it occurs in humans by injecting mice once 
with 7.4 mg/kgBW of AOM and giving them a drink containing 3% DSS 
for four cycles to trigger chronic ulcerative colitis. Several colon 
mucosal tumors, the majority of which were seen in the left colon 
(descending, sigmoid, and rectum) and transverse colon, were found 
in the AOM/DSS group. AOM demonstrates genotoxic (i.e., mutagenic) 
activity which is ideal to initiate carcinogenesis. Meanwhile, DSS 
creates chronic inflammation (colitis). Thus, both AOM and DSS play a 
role in the initiation and progression of carcinogenesis in animal 
models [16]. In this study, we attempted to mimic colorectal 
carcinogenesis with AOM/DSS as well, but with the dosage and 
method adopted by Kusmardi et al. [17]. 
Cytokines are produced due to carcinogen stimuli, infections, and 
inflammation. Among cytokines, TNF-α is the main mediator of 
inflammation [14]. The focus of this study was to assess TNF-α 
expression in colonic epithelial cells. TNF-α is a pro-inflammatory 
cytokine not only produced by inflammatory cells but also by other 
cells, including epithelial cells [18]. The results of this study indicate 
that there are significant differences in TNF-α expression between 
the normal and AOM/DSS-induced (negative control) groups. This 
suggests that AOM/DSS successfully creates an inflammatory 
condition so that TNF-α increases, as evidenced by the dark brown 
epithelial cells that were observed. 
The activation of the NF-κB pathway can explain why the expression 
of TNF-α increases during inflammation. NF-κB is a transcription 
factor found in cytoplasm that plays a role in inflammation and 
carcinogenesis. In unstimulated conditions, NF-κB is in an inactive 
state because it binds to the protein inhibitor κB (IκB) [14, 18]. NF-
κB can be activated if IκB becomes dissociated when there are 
stimuli, such as IL-1, TNF-α, LPS, DNA damage, double-stranded RNA 
(RNAds), cyclic adenosine monophosphate (cAMP), toll-like receptor 
(TLR) due to tissue damaged by microorganisms, hypoxia, and solid 
tumors. NF-κB regulates genes associated with inflammation, one of 
which is TNF-α, as well as proliferation; angiogenesis; survival; and 
tumor promotion and metastasis [14, 18]. Rogler et al. [19]. 
Observed the results of the biopsy of human intestinal mucosa that 
was undergoing inflammation and found that activated NF-κB was 
not only found in macrophages but also in epithelial cells. 
Although not given AOM/DSS, the colonic epithelial cytoplasm in the 
normal group was not completely blue (indicating a negative 
expression of TNF-α) but instead tended to be light brown in 
intensity. Considering that NF-κB can be activated by 
microorganisms through TLR, it is possible that microbiota (bacteria) 
in the mice’s colon stimulates the activation of NF-κB so that TNF-α 
is formed in small amounts. 
Aspirin therapy in colorectal carcinogenesis models 
This study used a dose of 150 mg/kgBW of aspirin, according to 
previous studies by Amalia et al. [17]. In this study, no significant 
differences in TNF-α expression were seen between the aspirin 
(positive control) group and the normal group, but a significant 
difference was seen between the positive control group and negative 
control group. This suggests that aspirin succeeded in reducing the 
amount of TNF-α in epithelial cells that had undergone colorectal 
carcinogenesis. Moreover, the TNF-α expression was similar to that 
of the normal group. 
Some studies have proven the relationship between aspirin use and 
a reduced risk of cancer. Low-dose aspirin (i.e., 81–160 mg) can 
reduce the risk of developing an adenoma [20]. However, the 
mechanism by which aspirin prevents CRC is still unknown. There 
are several possible mechanisms, including cyclooxygenase (COX)-
dependent pathways and COX-independent pathways. In COX-
dependent pathways, aspirin and its metabolites (sodium salicylate) 
can permanently inactivate COX-1 and COX-2, resulting in apoptosis 
and the inhibition of angiogenesis. Meanwhile, in COX-independent 
pathways, aspirin or salicylates inhibit the activity of IκB kinase (IKK) 
to prevent NF-κB activation, both in vivo and in vitro [20, 21]. As a 
result of NF-κB inhibition, TNF-α expression decreased in the 
positive control group. 
LSE therapy in colorectal carcinogenesis model 
After mice had undergone colorectal carcinogenesis, mice were 
treated with LSE at three different doses (250, 300, and 350 
mg/kgBW). These doses were determined based on previous studies 
by Amalia et al., [17]. Which showed that soybean extracts at doses 
of 150 and 200 mg/kgBW were able to increase apoptosis and 
significantly reduce dysplasia in the colon against negative controls. 
Soybeans were chosen because they have the highest lunasin 
content among other sources, at about 0.5–8.1 mg/g [22]. Lunasin 
content in this study was 0.823 mg/g of soybean extract, which falls 
within the projected range. 
The LSE-250 group did not show significant differences in TNF-α 
expression with negative controls. However, at higher doses (i.e., 
LSE-300 and LSE-350), significant differences with negative controls 
were observed. The higher the LSE doses was, the lower the TNF-α 
expression was, indicating a dose-dependent effect. A study by 
Hernández-Ledesma et al. [10] proved that the inhibitory effect of 
TNF-α on RAW 64.7 macrophage cells, in which inflammation was 
induced using LPS, was greater as the dose of lunasin increased. At 
200 µM lunasin, TNF-α decreased by 23%. Previous studies by de 
Mejia et al. [23]. showed that lunasin derived from soybeans can 
inhibit the inflammatory process through the NF-κB pathway. 
LSE-350 reduced the TNF-α expression significantly when compared 
to the negative control group but insignificantly when compared to 
the normal group. The result of immunohistochemical staining 
between these two groups was almost identical. This indicates that 
LSE-350 mg/kgBW can restore TNF-α expression to resemble that of 
the normal group. 
Although the results of LSE therapy showed the restoration of TNF-α 
expression, this result does not rule out the contribution of other 
contents in the soybean extract, which could also work as an anti-
inflammatory, such as isoflavones. Isoflavones have been known for 
their use in the treatment of hormone-related cancers, such as 
breast, cervical, and prostate cancers, by inducing apoptosis through 
mitochondrial pathways and NF-κB [9]. 
CONCLUSION 
LSE inhibits TNF-α expression in the colonic epithelium of Swiss 
Webster mice in which carcinogenesis has been induced with AOM/DSS, 
with significant inhibition at doses of 300 and 350 mg/kgBW. The 
inhibition of TNF-α expression increases as the dose of LSE increases (i.e., 
in a dose-dependent manner). At a dose of 350 mg/kgBW, TNF-α 
expression is very similar to that of the normal group. 
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